Reuters logo
BRIEF-Ortho Dermatologics announces FDA filing acceptance for IDP-118, novel plaque psoriasis treatment
2017年11月2日 / 中午12点15分 / 16 天前

BRIEF-Ortho Dermatologics announces FDA filing acceptance for IDP-118, novel plaque psoriasis treatment

Nov 2 (Reuters) - Valeant Pharmaceuticals International Inc

* Ortho Dermatologics announces U.S. FDA filing acceptance for IDP-118, novel plaque psoriasis treatment

* Valeant - ‍PDUFA date set for June 18, 2018 for IDP-118​‍​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below